Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125029642 | 12502964 | 2 | F | 20160526 | 20160718 | 20160628 | 20160801 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119200 | RANBAXY | 62.00 | YR | M | Y | 94.00000 | KG | 20160801 | CN | ES | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125029642 | 12502964 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Oral | 80 MG, QD | Y | U | 76477 | 80 | MG | ||||||
| 125029642 | 12502964 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | MORNING | 2000 | MG | Y | U | 0 | 500 | MG | ||||
| 125029642 | 12502964 | 3 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 4 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 7 | C | DARBEPOETIN ALFA | DARBEPOETIN ALFA | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 8 | C | ISOSORBIDE. | ISOSORBIDE | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 9 | C | NOVOMIX | INSULIN ASPART | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 10 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 11 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 125029642 | 12502964 | 12 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125029642 | 12502964 | 1 | Blood cholesterol increased |
| 125029642 | 12502964 | 2 | Osteomyelitis acute |
| 125029642 | 12502964 | 3 | Product used for unknown indication |
| 125029642 | 12502964 | 4 | Product used for unknown indication |
| 125029642 | 12502964 | 5 | Product used for unknown indication |
| 125029642 | 12502964 | 6 | Product used for unknown indication |
| 125029642 | 12502964 | 7 | Product used for unknown indication |
| 125029642 | 12502964 | 8 | Product used for unknown indication |
| 125029642 | 12502964 | 9 | Product used for unknown indication |
| 125029642 | 12502964 | 10 | Product used for unknown indication |
| 125029642 | 12502964 | 11 | Product used for unknown indication |
| 125029642 | 12502964 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125029642 | 12502964 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125029642 | 12502964 | Drug interaction | |
| 125029642 | 12502964 | Muscular weakness | |
| 125029642 | 12502964 | Myopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125029642 | 12502964 | 1 | 2002 | 0 | ||
| 125029642 | 12502964 | 2 | 20160522 | 0 |